Onderneming Medipharm Labs Corp Toronto S.E.
Aandelen
CA58504D1006
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canadian Adult Use and Wellness
31,0
%
| 13 | 60,2 % | 10 | 31,0 % | -22,96% |
Canadian Medical Cannabis - Other
29,9
%
| - | - | 10 | 29,9 % | - |
International Medical Cannabis
29,2
%
| 5 | 22,9 % | 10 | 29,2 % | +90,34% |
Canadian Medical Cannabis - Clinics
5,6
%
| - | - | 2 | 5,6 % | - |
Pharmaceutical and Business to Business
4,2
%
| 4 | 16,8 % | 1 | 4,2 % | -62,52% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
69,8
%
| 15 | 66,4 % | 23 | 69,8 % | +57,17% |
Australia
16,3
%
| 3 | 11,8 % | 5 | 16,3 % | +106,63% |
Germany
10,8
%
| 4 | 16,5 % | 4 | 10,8 % | -1,89% |
Other
3,0
%
| 1 | 5,3 % | 1 | 3,0 % | -14,02% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20-04-22 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08-02-21 |
Keith Strachan
PSD | President | - | 01-10-18 |
William Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-16 |
Kirk Binns
AUD | Comptroller/Controller/Auditor | - | 06-02-19 |
Ahmed Shehata
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01-04-23 |
David Pidduck
CEO | Chief Executive Officer | - | 20-04-22 |
Shelley Martin
BRD | Director/Board Member | - | 22-06-20 |
Chris Halyk
BRD | Director/Board Member | - | 04-08-20 |
Keith Strachan
PSD | President | - | 01-10-18 |
Chris Taves
CHM | Chairman | - | 13-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 404 233 466 | 385 092 308 ( 95,26 %) | 0 | 95,26 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,38% | 6,28 mld. | |
-15,86% | 4,51 mld. | |
+6,36% | 3,35 mld. | |
-11,28% | 3,13 mld. | |
-3,23% | 2,47 mld. | |
+45,24% | 1,96 mld. | |
-7,89% | 1,68 mld. | |
-0,98% | 1,63 mld. | |
-11,32% | 1,56 mld. |